In accordance with previous studies, activation of IGF1R contributed to the resistance of radiotherapy in lung cancer cells [27]; however, no data on BCL2L1 expression in LA or LSC is yet available to our knowledge. The gene discussed is IGF1R; the disease is lung carcinoma.